Results 101 to 110 of about 258,151 (309)
Pancreatic neuroendocrine tumors frequently silence MEN1 through epigenetic mechanisms. Here, SIRT7 recruits DNMT1 to the MEN1 promoter, drives hypermethylation, and enhances DNA repair. Inhibiting SIRT7 restores MEN1, reduces MRN complex abundance, impairs double‐strand break repair, and sensitizes PanNET models to radiation, supporting SIRT7 as a ...
Jianyun Jiang +11 more
wiley +1 more source
Background and pu,pose: Measurement of percent free prostate -specific antigen (fPSA) has been shown to enhance the diagnostic performance of traditional serum PSA determination.
LIAO, CHUN-HOU;LIU, SHIH-PING;PU, YEONG-SHIAU;HUANG, CHAO-YUAN;YU, HONG-JENG;CHEN, JUN +1 more
core
BACKGROUND. The nadir prostate-specific antigen (PSA) at 1 year (nPSA12) was investigated as an early estimate of biochemical and clinical outcome after radiotherapy (RT) alone for localized prostate cancer.
Alcántara Carrió, María Del Pino +4 more
core +1 more source
Icariin promoted the growth of Akk by enhancing the activity of N‐acetylgalactosaminidase (Amuc_0920), which enhanced mucin utilization and provided a favorable nutrient environment for bacterial growth. This icariin‐mediated enrichment of Akk further reshaped the tumor microenvironment and promoted CD8+ T cell infiltration, ultimately synergizing with
Shuangying Qiao +12 more
wiley +1 more source
Objectives: To find out the effect of bacterial urinary tract infection on prostate specific antigen levels in patients serum the secreted by the prostate gland.
Ali Jabbar Abd-Zaid AL-Kilaby +1 more
doaj +1 more source
Benign prostatic hyperplasia and prostate-specific antigen
nema
Pejčić Tomislav +4 more
openaire +3 more sources
Components of cell-matrix linkage as potential new markers for prostate cancer
Prostate cancer is one of the most common tumor diseases worldwide. Often being non-aggressive, prostate tumors in these cases do not need immediate treatment.
Alexey Navdaev +3 more
core +1 more source
The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: androgen-receptor cofactors and bypass pathways [PDF]
Prostate cancer is the second leading cause of cancer related deaths in men from the western world. Treatment of prostate cancer has relied on androgen deprivation therapy for the past 50 years.
J Edwards +3 more
core +1 more source
This study demonstrates that transcription factor androgen receptor (AR) directly binds the LF promoter, driving lactoferrin overexpression to promote ferritin (FTH1/FTL) upregulation and inhibit p53‐ALOX12‐mediated ferroptosis in prostate cancer. Lactoferrin could be a new potential therapeutic target in prostate cancer.
Can Liu +18 more
wiley +1 more source
Study of prostatic pathology and its correlation with prostate specific antigen level
Background: Diseases primarily inflicting prostate gland are inflammation, benign prostatic hyperplasia and cancer. Prostate specific antigen is a protein produced by the cells of prostate gland. It has been widely used in the diagnosis and management of
S Hirachand +3 more
doaj +1 more source

